---
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/42826077.md"
description: "$WUXI XDC(02268.HK) rose by five or six points; the story of ADC outsourcing capacity continues to lead in the sentiment of Hong Kong's innovative drug sector; $PHARMARON(03759.HK) saw a slight increase.On the US stock side, it's the opposite: $Moderna(MRNA.US) fell by nearly four points, with trust repair for its mRNA pipeline still far off; $Novo Nordisk AS(NVO.US) dipped slightly, as the competitive landscape for weight-loss drugs is being repriced daily.CXOs rely on order certainty, while large pharma bets on pipeline expectations. Going long on Chinese capacity and watching the US pipeline has become a worry-free combination for this period 😷"
datetime: "2026-07-21T10:46:06.000Z"
locales:
  - [en](https://longbridge.com/en/topics/42826077.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/42826077.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/42826077.md)
author: "[软乎乎的小熊](https://longbridge.com/en/profiles/27330473.md)"
---

# $WUXI XDC(02268.HK) rose by five or six points; th…


### Related Stocks

- [02268.HK](https://longbridge.com/en/quote/02268.HK.md)
- [MRNA.US](https://longbridge.com/en/quote/MRNA.US.md)
- [NVO.US](https://longbridge.com/en/quote/NVO.US.md)
- [03759.HK](https://longbridge.com/en/quote/03759.HK.md)
- [300759.CN](https://longbridge.com/en/quote/300759.CN.md)